Status:
TERMINATED
Optimal EGM Configuration for Morphology Discrimination
Lead Sponsor:
Abbott Medical Devices
Collaborating Sponsors:
Unity Health Toronto
Conditions:
Premature Ventricular Complexes
Eligibility:
All Genders
18+ years
Brief Summary
The study will be a prospective cohort study of 20 patients recruited from site's Defibrillator Clinic patient population who are followed at the site. Hypothesis: Among the available EGM configurati...
Eligibility Criteria
Inclusion
- Patients must already have an implanted St. Jude Medical dual chamber ICD with a dual coil defibrillator lead.
- Patients must be willing to sign an informed consent form.
- Patients must have frequent PVCs (minimum of 30/hour)
Exclusion
- Known history of slow VT (under 160 bpm).
- Patients under the age of 18 years.
- Pregnant women.
- Pacemaker dependent rhythm.
- Ongoing angina pectoris.
- Current NYHA Class 3-4 heart failure.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT00888667
Start Date
April 1 2009
End Date
May 1 2010
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Michael's Hospital
Toronto, Ontario, Canada, M5B1W8